エピソード

  • Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

    Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials
    2022/05/26
    • Overview of olipudase alfa
    • Efficacy and safety of olipudase alfa from phase 2 and 3 trials
    続きを読む 一部表示
    27 分
  • Clinical Management and Treatment Monitoring Part 2

    Clinical Management and Treatment Monitoring Part 2
    2022/05/26
    • Surveillance recommendations for patients with ASMD
    • Ongoing symptomatic management and support
    • Role of liver transplantation
    続きを読む 一部表示
    11 分
  • Clinical Management and Treatment Monitoring Part 1

    Clinical Management and Treatment Monitoring Part 1
    2022/05/26
    • Initial evaluation and management of ASMD
    • Clinical trial enrollment
    続きを読む 一部表示
    4 分
  • Guidelines for the Diagnosis of ASMD

    Guidelines for the Diagnosis of ASMD
    2022/05/26
    • Clinical presentations of ASMD
    • Diagnostic algorithms
    • Enzymatic testing
    続きを読む 一部表示
    12 分
  • Defining ASMD

    Defining ASMD
    2022/05/26
    • Pathophysiology of ASMD
    • ASMD phenotypes
    続きを読む 一部表示
    4 分